L-2-oxothiazolidine-4-carboxylic acid and glutathione in human immunodeficiency virus
- 30 September 1992
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 52 (3) , 461-467
- https://doi.org/10.1016/s0011-393x(05)80422-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Glutathione deficiency in human HIV infectionPharmacological Research, 1990
- SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALSThe Lancet, 1989
- Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected PatientsBiological Chemistry Hoppe-Seyler, 1989
- Immunopathogenic mechanisms of HIV infectionClinical Immunology and Immunopathology, 1989
- Reappraisal of Aids — Is the oxidation induced by the risk factors the primary cause?Medical Hypotheses, 1988
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Regulation of glutathione levels in mouse spleen lymphocytes by transport of cysteineJournal of Cellular Physiology, 1987
- Lymphocyte dysfunction after DNA damage by toxic oxygen species. A model of immunodeficiency.The Journal of Experimental Medicine, 1986
- Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: analysis of DNA synthesis in individual cells by BUdR quenching of hoechst 33258International Journal of Immunopharmacology, 1985
- New Developments in Glutathione Metabolism and Their Potential Application in TherapyHepatology, 1984